These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dapsone as treatment adjunct in ARDS. Kast RE Exp Lung Res; 2020; 46(5):157-161. PubMed ID: 32286085 [TBL] [Abstract][Full Text] [Related]
25. Dapsone-associated methaemoglobinaemia in patients with a haematologic malignancy. Subramaniam A; Corallo C; Nagappan R Anaesth Intensive Care; 2010 Nov; 38(6):1070-6. PubMed ID: 21226440 [TBL] [Abstract][Full Text] [Related]
26. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Speeg KV; Patwardhan RV; Avant GR; Mitchell MC; Schenker S Gastroenterology; 1982 Jan; 82(1):89-96. PubMed ID: 6118315 [TBL] [Abstract][Full Text] [Related]
28. [Hematologic effects of dapsone (Disulone)]. Bordessoule D; Liozon E; Cransac M; Bonnetblanc JM; Vidal E; Weinbreck P; Liozon F Rev Med Interne; 1989; 10(6):531-6. PubMed ID: 2488504 [No Abstract] [Full Text] [Related]
29. Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant. Talarico JF; Metro DG J Clin Anesth; 2005 Nov; 17(7):568-70. PubMed ID: 16297761 [TBL] [Abstract][Full Text] [Related]
30. Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. Pirmohamed M; Williams D; Tingle MD; Barry M; Khoo SH; O'Mahony C; Wilkins EG; Breckenridge AM; Park BK AIDS; 1996 May; 10(5):501-7. PubMed ID: 8724041 [TBL] [Abstract][Full Text] [Related]
31. A case of dapsone-induced methaemoglobinaemia. Tan YA; Ng KC; Cheo SW; Khoo TT; Low QJ Clin Med (Lond); 2020 Sep; 20(5):519-521. PubMed ID: 32934050 [TBL] [Abstract][Full Text] [Related]
32. Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex. Levine M; Bellward GD Drug Metab Dispos; 1995 Dec; 23(12):1407-11. PubMed ID: 8689952 [TBL] [Abstract][Full Text] [Related]
33. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. Coleman MD; Breckenridge AM; Park BK Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600 [TBL] [Abstract][Full Text] [Related]
34. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro. Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906 [TBL] [Abstract][Full Text] [Related]
35. Subtle case of dapsone-induced methaemoglobinaemia. Lewis JS; Jacobs ZG BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843412 [TBL] [Abstract][Full Text] [Related]
36. Dapsone-Induced Hemolytic Anemia in Multiple Myeloma: Case Report of Various Differential Diagnoses. Rassner M; Jung J; Schneider J; Wäsch R; Engelhardt M Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e821-e825. PubMed ID: 32753123 [No Abstract] [Full Text] [Related]
38. Inhibition of dapsone-induced methaemoglobinaemia in the rat. Coleman MD; Winn MJ; Breckenridge AM; Park BK Biochem Pharmacol; 1990 Feb; 39(4):802-5. PubMed ID: 2306285 [No Abstract] [Full Text] [Related]
39. Management of dapsone poisoning complicated by methaemoglobinaemia. Dawson AH; Whyte IM Med Toxicol Adverse Drug Exp; 1989; 4(5):387-92. PubMed ID: 2811676 [TBL] [Abstract][Full Text] [Related]